These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16368002)

  • 1. The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.
    Ouburg S; Spaargaren J; den Hartog JE; Land JA; Fennema JS; Pleijster J; Peña AS; Morré SA;
    BMC Infect Dis; 2005 Dec; 5():114. PubMed ID: 16368002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?
    den Hartog JE; Ouburg S; Land JA; Lyons JM; Ito JI; Peña AS; Morré SA
    BMC Infect Dis; 2006 Jul; 6():122. PubMed ID: 16859562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MICA gene polymorphisms with Chlamydia trachomatis infection and related tubal pathology in infertile women.
    Mei B; Luo Q; Du K; Huo Z; Wang F; Yu P
    Hum Reprod; 2009 Dec; 24(12):3090-5. PubMed ID: 19783834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1B (IL-1B) and interleukin-1 receptor antagonist (IL-1RN) gene polymorphisms are not associated with tubal pathology and Chlamydia trachomatis-related tubal factor subfertility.
    Murillo LS; Land JA; Pleijster J; Bruggeman CA; Peña AS; Morré SA
    Hum Reprod; 2003 Nov; 18(11):2309-14. PubMed ID: 14585879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of polymorphisms in the inflammasome-associated NLRP3 and miRNA-146A genes in the susceptibility to and tubal pathology of Chlamydia trachomatis infection.
    Wang W; Stassen FR; Surcel HM; Ohman H; Tiitinen A; Paavonen J; de Vries HJ; Heijmans R; Pleijster J; Morré SA; Ouburg S
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():95-103. PubMed ID: 20011700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility.
    den Hartog JE; Lyons JM; Ouburg S; Fennema JS; de Vries HJ; Bruggeman CA; Ito JI; Peña AS; Land JA; Morré SA
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():75-82. PubMed ID: 20011698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a mannose-binding lectin gene polymorphism and exposure to Chlamydia trachomatis on fallopian tube obstruction in Brazilian woman.
    Vinagre JG; Witkin SS; Ribeiro SC; Robial R; Fukazawa EI; Ortolani CC; Baracat EC; Linhares IM
    Arch Gynecol Obstet; 2019 Sep; 300(3):641-645. PubMed ID: 31286209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.
    Jansen ME; Branković I; Spaargaren J; Ouburg S; Morré SA
    Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple site sampling does not increase the sensitivity of Chlamydia trachomatis detection in infertility patients.
    Dietrich W; Rath M; Stanek G; Apfalter P; Huber JC; Tempfer C
    Fertil Steril; 2010 Jan; 93(1):68-71. PubMed ID: 18990379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility.
    den Hartog JE; Land JA; Stassen FR; Kessels AG; Bruggeman CA
    Hum Reprod; 2005 Apr; 20(4):986-90. PubMed ID: 15640255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women.
    Karimi O; Ouburg S; de Vries HJ; Peña AS; Pleijster J; Land JA; Morré SA
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():67-74. PubMed ID: 20011697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the multitarget Mikrogen Chlamydia trachomatis IgG ELISA in the prediction of tubal factor infertility (TFI) in subfertile women: comparison with the Medac MOMP IgG ELISA plus.
    van Ess EF; Ouburg S; Spaargaren J; Land JA; Morré SA
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28854690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology.
    Coppus SF; Land JA; Opmeer BC; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW; van der Steeg JW
    Hum Reprod; 2011 Nov; 26(11):3061-7. PubMed ID: 21926058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.
    Verweij SP; Karimi O; Pleijster J; Lyons JM; de Vries HJ; Land JA; Morré SA; Ouburg S
    Pathog Dis; 2016 Feb; 74(1):ftv107. PubMed ID: 26568059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human fallopian tube model for investigation of C. trachomatis infections.
    Jerchel S; Knebel G; König P; Bohlmann MK; Rupp J
    J Vis Exp; 2012 Aug; (66):. PubMed ID: 22907315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Seropositivity of Chlamydia Trachomatis and Tubal and/or Pelvic Pathology Detected by Diagnostic Laparoscopy in Subfertile Women.
    Begum N; Anwary SA; Alfazzaman M; Mahzabin Z; Deeba F; Mostafa MA; Akhter M; Rahman MM
    Mymensingh Med J; 2017 Oct; 26(4):840-845. PubMed ID: 29208873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between Chlamydia trachomatis antibody titers and tubal pathology assessed using transvaginal hydrolaparoscopy in infertile women.
    Shibahara H; Takamizawa S; Hirano Y; Ayustawati ; Takei Y; Fujiwara H; Tamada S; Sato I
    Am J Reprod Immunol; 2003 Jul; 50(1):7-12. PubMed ID: 14506923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.
    Hoenderboom BM; van Oeffelen AA; van Benthem BH; van Bergen JE; Dukers-Muijrers NH; Götz HM; Hoebe CJ; Hogewoning AA; van der Klis FR; van Baarle D; Land JA; van der Sande MA; van Veen MG; de Vries F; Morré SA; van den Broek IV
    BMC Infect Dis; 2017 Apr; 17(1):264. PubMed ID: 28399813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia antibody testing in subfertile women.
    Land JA; den Hartog JE
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():35-42. PubMed ID: 16683042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection.
    Ouburg S; Lyons JM; Land JA; den Hartog JE; Fennema JS; de Vries HJ; Bruggeman CA; Ito JI; Peña AS; Lundberg PS; Morré SA
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():83-93. PubMed ID: 20011699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.